Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Biocytogen RMB1.27 billion Shanghai IPO
We advised Biocytogen on its IPO and SSE listing
Denali Therapeutics $200 million stock and pre-funded warrants offering
We advised the representatives of the several underwriters on the offering
Immix Biopharma $100 million stock and pre-funded warrants offering
We advised the sole bookrunner and representative of the several underwriters on the offering
Mirum Pharmaceuticals $200 million private placement
We advised the placement agents on the transaction
Immatics $125 million follow-on offering
We advised Immatics on the offering
Merck $8 billion notes offering
We advised the underwriters on the notes offering
Illumina $500 million notes offering
We advised the underwriters on the offering
Olema Pharmaceuticals $218.5 million follow-on offering
We advised the underwriters on the offering
Bristol Myers Squibb $7 billion cash tender offer
We advised the dealer managers on the tender offer
Inventiva $172.5 million follow-on offering
We advised the underwriters on the offering